This investigation, originally published by O Bastidor, raises serious questions about regulatory impartiality in Brazil's capital markets. It examines allegations of conflicts of interest surrounding a key CVM opinion in the Oncoclínicas case and why the final decision could have far-reaching consequences for investor confidence.
[Go to the article]
Related articles
Who holds power accountable?
2026-10-06
Dino Gets It Right
2026-07-04